Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Procedure: axillary surgery de-escalation after NAT
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT05914402
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center Shanghai, China, 200032, Shanghai, Shanghai, China
Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC
Phase 2
Not yet recruiting
- Conditions
- Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 132
- Registration Number
- NCT05910034
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Phase 2
Recruiting
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8
- Interventions
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 43
- Registration Number
- NCT05907512
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
Recruiting
- Conditions
- Non Functioning Pancreatic Endocrine Tumor
- Interventions
- Other: Histopathological review, long-term prognosis and quality of life follow-up
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 800
- Registration Number
- NCT05907824
- Locations
- 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
Phase 3
Recruiting
- Conditions
- Breast CancerTriple Negative Breast Cancer
- Interventions
- Drug: Antivascular therapyDrug: Chemotherapy
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 548
- Registration Number
- NCT05909332
- Locations
- 🇨🇳
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
🇨🇳West China Hospital of Sichuan University, Chengdu, Sichuan, China
🇨🇳The First Hospital of China Medical University, Shenyang, Liaoning, China
Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer
Not Applicable
Recruiting
- Conditions
- Non-metastatic Colorectal CancerCirculating Tumor DNA Methylation
- Interventions
- Diagnostic Test: ctDNA methylation dynamic monitoring
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 526
- Registration Number
- NCT05904665
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
Phase 3
Recruiting
- Conditions
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1736
- Registration Number
- NCT05901428
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT05897268
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions
Not yet recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 800
- Registration Number
- NCT05892380
- Locations
- 🇨🇳
Fudan university Shanghai Cancer Center, Shanghai, Shanghai, China
Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)
Phase 2
Recruiting
- Conditions
- Gastric Cancer Metastatic to Liver
- Interventions
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT05893056
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath